Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 8,089 | 8,577 | 9,417 | 9,410 | 8,901 |
| Cost of Goods | 5,908 | 5,548 | 6,344 | 5,987 | 6,171 |
| Gross Profit | 2,181 | 3,029 | 3,074 | 3,423 | 2,730 |
| Operating Expenses | 4,484 | 5,367 | 4,504 | 6,465 | 4,197 |
| Operating Income | -1,396 | -1,790 | -1,087 | -2,055 | -1,296 |
| Other Income | 152 | 57 | 65 | 75 | 76 |
| Pre-tax Income | -1,244 | -1,733 | -1,021 | -1,980 | -1,220 |
| Income Tax | 0 | 408 | -137 | -209 | -40 |
| Net Income Continuous | -1,244 | -2,141 | -884 | -1,771 | -1,180 |
| Net Income | $-1,244 | $-2,141 | $-884 | $-1,771 | $-1,180 |
| EPS Basic Total Ops | -2.50 | -4.20 | -1.90 | -3.90 | -4.40 |
| EPS Basic Continuous Ops | -2.54 | -4.13 | -1.94 | -3.94 | -4.36 |
| EPS Diluted Total Ops | -2.50 | -4.20 | -1.90 | -3.90 | -4.40 |
| EPS Diluted Continuous Ops | -2.54 | -4.13 | -1.94 | -3.94 | -4.36 |
| EPS Diluted Before Non-Recurring Items | -2.50 | -4.60 | -1.90 | -3.90 | -4.40 |
| EBITDA(a) | $-1,319 | $-1,560 | $-436 | $-920 | $-1,231 |